 |
|
Fasting Triglyceride and the Triglyceride–HDL Cholesterol Ratio Are Not Markers of Insulin Resistance in African Americans
Anne E. Sumner, MD;
Karl B. Finley, MD;
David J. Genovese, RN;
Michael H. Criqui, MD, MPH;
Raymond C. Boston, PhD
Arch Intern Med. 2005;165:1395-1400.
ABSTRACT
| |
Background The "lipid criteria" consist of a triglyceride (TG) level of 130 mg/dL (1.47 mmol/L) or greater and a ratio of TG to high-density lipoprotein cholesterol (HDL-C) of 3 or greater. In Caucasians, the lipid criteria predict insulin resistance in individuals with a body mass index (BMI) of 25 kg/m2 or greater. Our goal was to determine whether TG levels or TG–HDL-C ratio predicted insulin resistance in African Americans with a BMI of 25 kg/m2 or more.
Methods Of 125 African Americans, the 98 with a BMI of 25 kg/m2 or more participated. All subjects had frequently sampled intravenous glucose tolerance tests with insulin resistance determined by the insulin sensitivity index. Subjects were divided into the following tertiles by insulin sensitivity: 12.8 to 4.3, 4.2 to 2.3, and 2.2 to 0.2 mU/L per minute. Insulin resistance was defined as being in the third tertile. Across tertiles, the distribution of variables was compared by 1-way analysis of variance. Areas under the receiver operating characteristic curve were determined to identify variables that predicted insulin resistance.
Results Fasting insulin level, BMI, and waist circumference increased across tertiles (all P<.01), but TG levels and TG–HDL-C ratio did not (all P .3). The mean ± SE areas under the curves for fasting insulin, BMI, and waist circumference were 0.85 ± 0.04, 0.72 ± 0.05, and 0.71 ± 0.05, respectively. For TG level and TG–HDL-C ratio, the areas under the curves were 0.55 ± 0.06 and 0.56 ± 0.06, respectively, meaning that the true-positive rate was nearly equal to the false-positive rate. Therefore, they could not be used as markers of insulin resistance. Furthermore, 17 subjects met the lipid criteria but only 7 were in the insulin-resistant tertile, making the sensitivity of these criteria to identify insulin resistance only 17%.
Conclusion In African Americans, TG levels and TG–HDL-C ratio are not reliable markers of insulin resistance.
INTRODUCTION
The National Cholesterol Education Program Adult Treatment Panel III designed the criteria for metabolic syndrome to identify individuals at high risk for cardiovascular events.1 Five criteria are used to diagnose the metabolic syndrome: elevated triglyceride (TG) levels, low levels of high-density lipoprotein cholesterol (HDL-C), impaired fasting glucose, central obesity, and hypertension. For diagnosis of the metabolic syndrome, 3 of the 5 criteria must be present. Surprisingly, the prevalence of the metabolic syndrome is lower in African Americans than in Caucasians.2 This is unexpected because the prevalence of heart disease and insulin resistance is higher in African Americans than in Caucasians.3-4 The reason for underdiagnosis of the metabolic syndrome in African Americans is attributed to the reliance of the metabolic syndrome criteria on lipids, particularly TG levels.5 Of the 5 metabolic syndrome criteria, African Americans are least likely to fulfill the TG criteria.2 In an attempt to overcome this problem and fully identify the metabolic syndrome in African American children, race-adjusted TG levels have been reported.6
The metabolic syndrome is often used synonymously with insulin resistance, but the metabolic syndrome is not a diagnostic test for insulin resistance.7 Tests designed to measure insulin resistance include the glucose clamp, the insulin suppression test, and the frequently sampled intravenous glucose tolerance test.7-9
When the metabolic syndrome is used as a test for insulin resistance, missed diagnoses occur. In fact, Cheal et al7 determined that the sensitivity of the metabolic syndrome to detect insulin resistance was only 46%. In another investigation,these same investigators found that in subjects with a body mass index (BMI) of 25 kg/m2 or more (calculated as weight in kilograms divided by the square of height in meters), the lipid criteria, specifically TG levels and TG–HDL-C ratio, were sensitive markers of insulin resistance.8 They found that the cutoffs for the lipid criteria that were most predictive of insulin resistance were TG level of 130 mg/dL (1.47 mmol/L) or more and/or TG–HDL-C ratio of 3 (1.8) or more. However, the population they studied was only 1% African American. We undertook this investigation because we considered that the use of these 2 criteria might lead to underdiagnosis of insulin resistance in African Americans. The basis for our concern is that African Americans are more insulin resistant than Caucasians are, but have lower TG levels.4, 10 Therefore, TG levels that predict the presence of insulin resistance in Caucasians may not apply to African Americans. The consequence of underdiagnosis of insulin resistance in African Americans is that the opportunity for intervention to prevent cardiovascular disease and diabetes could be lost. Our goal was to determine whether the lipid criteria, specifically TG levels or the TG–HDL-C ratio, can be used to identify insulin resistance in African Americans with a BMI of 25 kg/m2 or greater.
METHODS
One hundred twenty-five African Americans (65 men and 60 women), with a mean ± SD age of 35 ± 8 years (range, 20-50 years) enrolled in the cross-sectional Triglyceride and Cardiovascular Risk in African Americans (TARA) study at the National Institutes of Health (NIH). Subjects were recruited from the Washington, DC, area by flyers and the NIH Web site. The women were premenopausal. None of the women was receiving exogenous estrogens. Subjects did not have diabetes, liver disease, or kidney disease and took no medication. Similar to data from the National Health and Nutrition Examination Survey, 42% of the subjects were obese, 22% were glucose intolerant, and 20% were hypertensive.11-13 Seventy-five percent of subjects either had less than 1 drink a week or denied all alcohol intake. Nineteen percent had a drink once a week, and 6% of subjects had more than 1 drink per week. The study was approved by the institutional review board of the NIH, and subjects gave informed consent.
MEASURING INSULIN RESISTANCE
Insulin resistance was determined from the insulin sensitivity index (SI) calculated from the minimal model equations using data from the insulin-modified frequently sampled intravenous glucose tolerance test14 (MinMOD Millenium version 6.01, MinMOD Inc, Los Angeles, Calif). The SI is a dynamic measure of insulin sensitivity that is highly correlated with insulin resistance determined by the steady-state glucose clamp technique.14
The frequently sampled intravenous glucose tolerance test was performed at 8 AM after a 12-hour fast. At time 0, glucose (0.3 g/kg) was injected. From 20 to 25 minutes, an insulin infusion was administered (4 mU/kg per minute). Glucose and insulin concentrations were determined at –10, –1, 0, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 16, 19, 22, 23, 24, 25, 27, 30, 40, 50, 60, 70, 80, 90, 100, 120, 150, and 180 minutes.
The 125 subjects were divided into tertiles by SI; these tertiles were 12.8 to 4.3, 4.2 to 2.3, and 2.2 to 0.2 mU/L per minute. The lower the value of SI, the greater the degree of insulin resistance. Insulin resistance was defined as being in the third tertile. Insulin resistance is well captured in this third tertile because conditions associated with insulin resistance such as obesity, glucose intolerance, and type 2 diabetes typically have SI values below 2.3 mU/L per minute.15-16 Normal SI is 5.0 mU/L per minute.15
We followed the study design of McLaughlin et al,8 the initial investigators who described that TG level and TG–HDL-C ratio were useful predictors of insulin resistance in Caucasians with a BMI of 25 kg/m2 or greater. From our population of 125 subjects, 98 had a BMI at that level. To determine whether any of the variables measured could be used to predict the presence of insulin resistance in African Americans with a BMI of 25 kg/m2 or greater, we analyzed the distribution of these 98 subjects across the SI tertiles determined by the population of 125.
ANALYTIC METHODS
Variables measured were fasting glucose, insulin, TG, HDL-C, TG–HDL-C ratio, very low-density lipoprotein particle size (VLDL size), low-density lipoprotein particle size (LDL size), and HDL size. Glucose was determined by the glucose oxidase method (Glucostat; Yellow Springs Instrument, Yellow Springs, Ohio). Insulin was measured with double-antibody chemiluminescent sandwich assays (Diagnostic Products, Los Angeles, Calif). Triglycerides were analyzed by enzymatic methods and an automated analyzer (Hitachi 917; Boehringer Mannheim, Mannheim, Germany). The HDL-C was isolated with dextran sulfate–magnesium2+.17 The coefficients of variation for the TG and HDL-C assays were 1.5% and 2.2%, respectively. Lipid particle diameters were determined by nuclear magnetic spectroscopy (LipoScience, Raleigh, NC).18
STATISTICAL ANALYSIS
Data are presented as mean ± SD. Parameters not normally distributed were transformed. Because results did not vary when adjusted for sex, combined results are presented. Tertile distributions of the 98 subjects with a BMI of 25 kg/m2 or greater were compared by 1-way analysis of variance with Bonferroni corrections for multiple comparisons. Categorical data were analyzed with  2 and Fisher exact tests. In addition, areas under the receiver operating characteristic (ROC) curves were determined for each variable to identify which were predictors of insulin resistance. Areas under the ROC curves are provided with standard errors. An ROC curve is a plot of the sensitivity (true positive) vs 1 – specificity (false positive) for each potential marker tested.19 The area under the ROC curve is a summary of the overall diagnostic accuracy of the test.19 The best markers have ROC curves that are shifted to the left with areas under the curve near unity. Nondiagnostic markers are represented by diagonals with areas under the ROC curves near 0.5.8, 19 Analyses were performed with Stata software, version 8.0 (Stata Corp, College Station, Tex).
RESULTS
The demographic characteristics of the 125 participants are provided in Table 1. The tertiles of SI were determined on the basis of this population of 125. Of these subjects, 98 had a BMI of 25 kg/m2 or greater. Twenty-seven of the 98 were in the first tertile of SI, 30 were in the second, and 41 were in the third (Table 2). Fasting insulin level, BMI, and waist circumference increased significantly across tertiles; fasting glucose level, TG level, HDL-C level, TG–HDL-C ratio, VLDL size, LDL size, and HDL size did not.
|
|
|
|
Table 1. Demographic and Metabolic Characteristics
|
|
|
|
|
|
|
Table 2. Characteristics by Insulin Resistance Tertile of Subjects With BMI Greater Than 25 kg/m2*
|
|
|
Relating to the 5 metabolic syndrome criteria, 5 subjects (5%) had TG levels of 150 mg/dL (1.70 mmol/L) or more, but 60 subjects (61%) had central obesity (waist circumference 102 cm for men, 88 cm for women), 34 (35%) had low HDL-C levels ( 40 mg/dL [1.03 mmol/L] for men, 50 mg/dL [1.29 mmol/L] for women), 24 (25%) had hypertension (blood pressure 130/85 mm Hg), and 10 (10%) had impaired fasting glucose levels (100 mg/dL [5.55 mmol/L]). For the 17 subjects (17%) who met the lipid criteria, 6 (6%) met both criteria (TG130 mg/dL [1.47 mmol/L] and TG–HDL-C ratio 3.0 [1.8]), 4 (4%) met only the TG criterion, and 7 (7%) met only the TG/HDL-C ratio criterion.
Fourteen subjects had the metabolic syndrome, but only 12 of these were in the insulin-resistant tertile (Table 2). The sensitivity, specificity, and positive predictive value of the metabolic syndrome to diagnose insulin resistance in African Americans were 30%, 96%, and 86%, respectively. Of the 17 subjects who met the lipid criteria, only 7 were in the insulin-resistant tertile. The sensitivity, specificity, and positive predictive value of the lipid criteria to identify African Americans with insulin resistance were 17%, 83%, and 41%, respectively.
The ROC curve analyses showed that the best marker of insulin resistance was fasting insulin level, with an area under the ROC curve of 0.85 ± 0.04 (Table 3; Figure, A). The BMI and waist circumference also discriminated insulin resistance, as they had areas under the ROC curve of 0.72 ± 0.05 and 0.71 ± 0.05, respectively. Level of TG and the TG–HDL-C ratio were not effective markers of insulin resistance. The areas under the ROC curve for these were 0.55 ± 0.06 and 0.56 ± 0.06, respectively (Figure, B and C). In addition, the TG-related variables of VLDL size, LDL size, and HDL size had areas under the ROC curve that were near 0.5.
|
|
|
|
Table 3. Comparison of Areas Under ROC Curves for Potential Markers of Insulin Resistance
|
|
|
|
|
|
|
Figure. Receiver operating characteristic curves. Sensitivity represents true-positive results, and 1 – specificity, false-positive results. A, Fasting insulin concentration. B, Triglyceride concentration. C, Triglyceride–high-density lipoprotein cholesterol ratio.
|
|
|
COMMENT
The goal of this study was to determine whether lipid criteria, specifically the TG level or the TG–HDL-C ratio, were markers of insulin resistance in African Americans. As both the TG level and the TG–HDL-C ratio had areas under the ROC curve that approached 0.5, neither was a useful marker of insulin resistance in African Americans. The inability of the TG level or the TG–HDL-C ratio to be an effective marker of insulin resistance is reinforced by 2 observations: first, the TG level and the TG–HDL-C ratio did not increase across SI tertiles; second, VLDL size, LDL size, and HDL size did not change significantly across tertiles and had areas under the ROC curve that approached 0.5. The size of these lipid particles relates to TG levels because if TG had increased significantly across SI tertiles, the size of the particles should have decreased significantly.20
Because neither TG level nor TG–HDL-C ratio was a marker of insulin resistance in African Americans, no threshold value or cutoff could be calculated. According to McLaughlin et al,8 cutoff levels that are diagnostic of insulin resistance in Caucasians are 130 mg/dL (1.47 mmol/L) or greater for TG level and 3 (1.8) or greater for TG–HDL-C ratio. When we applied these cutoffs to African Americans, we found that only 17 of 98 subjects met one of these criteria. Of these 17 subjects, only 7 were in the insulin-resistant tertile. Therefore, the lipid criteria had a sensitivity of only 17% in African Americans when used to diagnose insulin resistance.
In contrast to TG level and TG–HDL-C ratio, fasting insulin, BMI, and waist circumference were excellent markers of insulin resistance. Hence, African Americans have the expected relationship between insulin resistance and increased body size. However, studies have demonstrated that the strength of the correlation between obesity and TG levels is lower in African Americans than in Caucasians.21-22 Clearly, in African Americans the interrelationship between insulin resistance, obesity, and TG is not yet fully defined and cannot be extrapolated from studies in Caucasians.
As the metabolic syndrome does not rely solely on lipid measures, we postulated that the sensitivity of the metabolic syndrome to diagnose insulin resistance may be superior to that of the lipid criteria. Indeed, the sensitivity and positive predictive value of the metabolic syndrome were 30% and 86%, respectively, compared with 17% and 41% for the lipid criteria. Therefore, in African Americans the metabolic syndrome is somewhat superior to the lipid criteria in the identification of subjects with insulin resistance. Nonetheless, the metabolic syndrome had a sensitivity of only 30%. The sensitivity for the metabolic syndrome to diagnose insulin resistance is still relatively low at 30% because there were 29 of 41 subjects in the third SI tertile who had insulin resistance but were undiagnosed because they did not carry the metabolic syndrome label. Therefore, as found by McLaughlin et al8 in Caucasians, relying on the diagnosis of the metabolic syndrome to identify insulin resistance leads to underdiagnosis of insulin resistance. For African Americans, the poor relationship between insulin resistance and either the metabolic syndrome or the lipid criteria may be due to a low correlation between TG level and insulin resistance.
Racial differences in lipoprotein lipase (LPL) activity may be responsible for racial differences in TG. Lipoprotein lipase is the enzyme responsible for clearing TG-containing lipoproteins from the circulation.23 The LPL levels are higher in African Americans than in Caucasians.24 This is the reason most often cited as to why African Americans have lower TG levels than Caucasians.24 In Caucasians, insulin resistance leads to an impairment of LPL levels and high TG levels.23 There is some evidence that insulin resistance may not lead to an impairment of LPL activity in African Americans.25 If that is the case, then TG-containing lipid particles are cleared from the circulation even in the presence of insulin resistance and plasma TG levels do not rise. This could account in part for a weak association between TG levels and insulin resistance in African Americans.
Our conclusions differ from those of McLaughlin et al, but there are 3 major differences between our studies. First, all of our participants were African Americans. In the McLaughlin et al study, 87% of the participants were Caucasian and only 1% were African American. The differences in our results most likely represent important racial differences. Second, McLaughlin et al used the insulin suppression test to measure insulin resistance, while we used SI. As both methods are valid measures of insulin resistance, this difference in technique should have had little impact. Third, the age range in our study was 20 to 50 years, while in their study the age range was 19 to 70 years. Therefore, our results are applicable only to African Americans 20 to 50 years old. However, we believe our results would probably not change if older African Americans were included. We make this judgment because even above the age of 50 years, African Americans have lower TG and higher HDL-C levels than do Caucasians.10 In addition, the prevalence of the metabolic syndrome increases with age in African Americans because of a rise in central obesity, hypertension, and fasting hyperglycemia but not dyslipidemia.2 Nevertheless, the ability of both the metabolic syndrome and the lipid criteria to identify older African Americans with insulin resistance needs to be tested.
We suggest that using lipid criteria, specifically TG level or the TG–HDL-C ratio, in African Americans to diagnose insulin resistance will lead to an underestimation of risk for disorders related to insulin resistance. Before recommendations are made to use TG level and TG–HDL-C ratio as markers of insulin resistance in African Americans, we urge testing these criteria in large populations of African Americans over a wide age range.
AUTHOR INFORMATION
Correspondence: Anne E. Sumner, MD, Clinical Endocrinology Branch, NIDDK, NIH, 9000 Rockville Pike, Bldg 10-CRC, Room 6W-5940, Bethesda, MD 20892 (AnneS{at}intra.niddk.nih.gov).
Accepted for Publication: January 11, 2005.
Funding/Support: This study was supported by intramural funding on the National Institutes of Health (NIH) campus from the National Institute of Diabetes and Digestive and Kidney Diseases and by the National Center on Minority Health and Health Disparities, NIH.
Previous Presentation: This work was presented as a poster at the national meeting of the American Diabetes Association; June 4-8, 2004; Fort Lauderdale, Fla.
Acknowledgment: We thank Tamara Harris, MD, for her thoughtful review of the manuscript. We also thank Donna Hardwick, RN, and the nursing staff of the Clinical Research Center, National Institutes of Health, Bethesda, Md, for their support and hard work. Additionally, we express great appreciation to the subjects who participated.
Financial Disclosure: None.
Author Affiliations: Clincial Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md (Drs Sumner and Finley and Mr Genovese); Department of Family and Preventive Medicine, University of California at San Diego (Dr Criqui); and Center for Biostatistics, University of Pennsylvania, Philadelphia (Dr Boston).
REFERENCES
| |
1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
FREE FULL TEXT
2. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-436.
FREE FULL TEXT
3. Clark LT, Ferdinand KC, Flack JM, et al. Coronary heart disease in African Americans. Heart Dis. 2001;3:97-108.
FULL TEXT
| PUBMED
4. Haffner SM, D’Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45:742-748.
ABSTRACT
5. Giannini E, Testa R. The metabolic syndrome: all criteria are equal, but some criteria are more equal than others. Arch Intern Med. 2003;163:2787-2788.
FREE FULL TEXT
6. Weiss R, Dziura J, Burget TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-2374.
FREE FULL TEXT
7. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes. 2004;53:1195-1200.
FREE FULL TEXT
8. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven GM. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802-809.
FREE FULL TEXT
9. Bergman RN, Hope ID, Yang YJ, et al. Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev. 1989;5:411-429.
ISI
| PUBMED
10. Brown SA, Hutchinson R, Morrisett J, et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1993;13:1139-1158.
FREE FULL TEXT
11. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents and adults, 1999-2002. JAMA. 2004;291:2847-2850.
FREE FULL TEXT
12. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1998-1994. Diabetes Care. 1998;21:518-524.
ABSTRACT
13. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
FREE FULL TEXT
14. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79:790-800.
15. Bergman RN. Toward physiological understanding of glucose tolerance, minimal-model approach. Diabetes. 1989;38:1512-1527.
ABSTRACT
16. Osei K, Gaillard T, Schuster DP. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African Americans. Diabetes Care. 1997;20:396-404.
ABSTRACT
17. Warnick GR, Benderson J, Albers JJ. Dextran sulfate–Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
FREE FULL TEXT
18. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem. 1992;38:1632-1638.
FREE FULL TEXT
19. Rosner B. Fundamentals of Biostatistics. 5th ed. Pacific Grove, Calif: Duxbury Thomas Learning; 2000.
20. Taskinen MR. LDL-cholesterol, HDL-cholesterol or triglycerides: which is the culprit? Diabetes Res Clin Pract. 2003;61(suppl 1):S19-S26.
21. Gillum RF. Indices of adipose tissue distribution, apolipoproteins B and A1, lipoprotein(a) and triglyceride concentration in children aged 4-11 years: the Third National Health and Nutrition Examination Survey. J Clin Epidemiol. 2001;54:367-375.
FULL TEXT
|
ISI
| PUBMED
22. MacLean PS, Bower JF, Vadlamudi S, Green T, Barakat HA. Lipoprotein subpopulation distributions in lean, obese and type 2 diabetic women: a comparison of African and white Americans. Obes Res. 2000;8:62-70.
ISI
| PUBMED
23. Eckel RH, Yost TJ, Jensen D. Alterations in lipoprotein lipase in insulin resistance. Int J Obes. 1995;19(suppl 1):S16-S21.
ISI
24. Despres J-P, Couillard C, Gagnon J, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol. 2000;20:1932-1938.
FREE FULL TEXT
25. Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African-Americans: role of lipoprotein lipase. Metabolism. In press.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Why the Plasma TG/HDL-C Concentration Ratio Does Not Predict Insulin Resistance in African Americans
Gerald Reaven and Traceu McLaughlin
Arch Intern Med. 2006;166(2):249.
EXTRACT
| FULL TEXT
Why the Plasma TG/HDL-C Concentration Ratio Does Not Predict Insulin Resistance in African Americans—Reply
Anne E. Sumner
Arch Intern Med. 2006;166(2):249-250.
EXTRACT
| FULL TEXT
The Prediction of Insulin Resistance With Serum Triglyceride and High-Density Lipoprotein Cholesterol Levels in an East African Population
Pascal Bovet, David Faeh, Anne Gabriel, and Luc Tappy
Arch Intern Med. 2006;166(11):1236-1237.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
In Vivo Insulin Sensitivity and Lipoprotein Particle Size and Concentration in Black and White Children
Burns et al.
Diabetes Care 2009;32:2087-2093.
ABSTRACT
| FULL TEXT
Evaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal
Periwal et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;295:R1089-R1096.
ABSTRACT
| FULL TEXT
Effect of Low-Dose Oral Contraceptives on Metabolic Risk Factors in African-American Women
Frempong et al.
J. Clin. Endocrinol. Metab. 2008;93:2097-2103.
ABSTRACT
| FULL TEXT
Association of serum lipid indices with large artery atherosclerotic stroke
Bang et al.
Neurology 2008;70:841-847.
ABSTRACT
| FULL TEXT
The prediction of insulin resistance with serum triglyceride and high-density lipoprotein cholesterol levels in an East african population.
Bovet et al.
Arch Intern Med 2006;166:1236-1237.
FULL TEXT
Increased Fasting Triglyceride Levels Are Associated With Hepatic Insulin Resistance in Caucasian but Not African-American Adolescents.
Hoffman
Diabetes Care 2006;29:1402-1404.
FULL TEXT
Why the Plasma TG/HDL-C Concentration Ratio Does Not Predict Insulin Resistance in African Americans
Reaven and McLaughlin
Arch Intern Med 2006;166:249-249.
FULL TEXT
Why the Plasma TG/HDL-C Concentration Ratio Does Not Predict Insulin Resistance in African Americans--Reply
Sumner
Arch Intern Med 2006;166:249-250.
FULL TEXT
|
